155 related articles for article (PubMed ID: 16423959)
1. Diagnosis of duct disruption and assessment of pancreatic leak with dynamic secretin-stimulated MR cholangiopancreatography.
Gillams AR; Kurzawinski T; Lees WR
AJR Am J Roentgenol; 2006 Feb; 186(2):499-506. PubMed ID: 16423959
[TBL] [Abstract][Full Text] [Related]
2. Administration of secretin (RG1068) increases the sensitivity of detection of duct abnormalities by magnetic resonance cholangiopancreatography in patients with pancreatitis.
Sherman S; Freeman ML; Tarnasky PR; Wilcox CM; Kulkarni A; Aisen AM; Jacoby D; Kozarek RA
Gastroenterology; 2014 Sep; 147(3):646-654.e2. PubMed ID: 24906040
[TBL] [Abstract][Full Text] [Related]
3. Pancreas divisum and santorinicele: assessment by dynamic magnetic resonance cholangiopancreatography during secretin stimulation.
Manfredi R; Brizi MG; Costamagna G; Masselli G; Vecchioli Scaldazza A; Marano P
Radiol Med; 2002; 103(1-2):55-64. PubMed ID: 11859301
[TBL] [Abstract][Full Text] [Related]
4. Pancreas divisum and "santorinicele": diagnosis with dynamic MR cholangiopancreatography with secretin stimulation.
Manfredi R; Costamagna G; Brizi MG; Spina S; Maresca G; Vecchioli A; Mutignani M; Marano P
Radiology; 2000 Nov; 217(2):403-8. PubMed ID: 11058635
[TBL] [Abstract][Full Text] [Related]
5. Main pancreatic duct: morphlogy after acute biliary pancreatitis with magnetic resonance cholangiopancreatography after secretin stimulation.
Pareja E; Artigues E; Mir J; Fabra R; Martínez V; Vázquez A; Trullenque R
Rev Esp Enferm Dig; 2003 Jun; 95(6):395-400, 389-94. PubMed ID: 12852778
[TBL] [Abstract][Full Text] [Related]
6. Severe chronic pancreatitis versus suspected pancreatic disease: dynamic MR cholangiopancreatography after secretin stimulation.
Manfredi R; Costamagna G; Brizi MG; Maresca G; Vecchioli A; Colagrande C; Marano P
Radiology; 2000 Mar; 214(3):849-55. PubMed ID: 10715057
[TBL] [Abstract][Full Text] [Related]
7. Exocrine pancreatic function assessed by secretin cholangio-Wirsung magnetic resonance imaging.
Calculli L; Pezzilli R; Fiscaletti M; Casadei R; Brindisi C; Gavelli G
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):192-5. PubMed ID: 18397857
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of magnetic resonance cholangiopancreatography in identifying pancreatic duct disruption.
Drake LM; Anis M; Lawrence C
J Clin Gastroenterol; 2012 Sep; 46(8):696-9. PubMed ID: 22565603
[TBL] [Abstract][Full Text] [Related]
9. MRCP-secretin test-guided management of idiopathic recurrent pancreatitis: long-term outcomes.
Testoni PA; Mariani A; Curioni S; Zanello A; Masci E
Gastrointest Endosc; 2008 Jun; 67(7):1028-34. PubMed ID: 18179795
[TBL] [Abstract][Full Text] [Related]
10. Can MRCP replace ERCP for the diagnosis of autoimmune pancreatitis?
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Kodama M; Kamata N
Abdom Imaging; 2009; 34(3):381-4. PubMed ID: 18437450
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic chronic pancreatitis in children: MR cholangiopancreatography after secretin administration.
Manfredi R; Lucidi V; Gui B; Brizi MG; Vecchioli A; Maresca G; Dall'Oglio L; Costamagna G; Marano P
Radiology; 2002 Sep; 224(3):675-82. PubMed ID: 12202699
[TBL] [Abstract][Full Text] [Related]
12. Correlation between secretin-enhanced MRCP findings and histopathologic severity of chronic pancreatitis in a cat model.
Zhang TT; Wang L; Wang DB; Huang ZJ; Li YH; Lu JP
Pancreatology; 2013; 13(5):491-7. PubMed ID: 24075513
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic duct: morphologic and functional evaluation with dynamic MR pancreatography after secretin stimulation.
Matos C; Metens T; Devière J; Nicaise N; Braudé P; Van Yperen G; Cremer M; Struyven J
Radiology; 1997 May; 203(2):435-41. PubMed ID: 9114101
[TBL] [Abstract][Full Text] [Related]
14. [Enhanced delineation of the pancreatic duct in MR cholangiopancreatography (MRCP) with a combined use of secretin].
Takehara Y; Ichijo K; Tooyama N; Kodaira N; Fujiwara T; Yamamoto H; Watahiki H; Kaneko M
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Mar; 55(4):255-6. PubMed ID: 7746728
[TBL] [Abstract][Full Text] [Related]
15. Pancreas divisum: evaluation with secretin-enhanced magnetic resonance cholangiopancreatography.
Matos C; Metens T; Devière J; Delhaye M; Le Moine O; Cremer M
Gastrointest Endosc; 2001 Jun; 53(7):728-33. PubMed ID: 11375579
[TBL] [Abstract][Full Text] [Related]
16. The effect of prior sphincterotomy on the secretin-stimulated magnetic resonance cholangiopancreatography (s-MRCP).
Chopra A; Alkaade S; Balci NC; Burton F
Acad Radiol; 2009 Nov; 16(11):1381-5. PubMed ID: 19683944
[TBL] [Abstract][Full Text] [Related]
17. Neostigmine® Improves Pancreatic Duct Visualization in Magnetic Resonance Cholangiopancreatography and Could Be a Cheap Alternative for Secretin.
Toledo PF; Cárdenas G; Berger Z; Simian D; Araya F
Turk J Gastroenterol; 2022 Aug; 33(8):704-709. PubMed ID: 35946885
[TBL] [Abstract][Full Text] [Related]
18. Role of MR cholangiopancreatography in patients with failed or inadequate ERCP.
Varghese JC; Farrell MA; Courtney G; Osborne H; Murray FE; Lee MJ
AJR Am J Roentgenol; 1999 Dec; 173(6):1527-33. PubMed ID: 10584796
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic ductal abnormalities documented by secretin-enhanced MRCP in asymptomatic subjects with chronic pancreatic hyperenzymemia.
Testoni PA; Mariani A; Curioni S; Giussani A; Masci E
Am J Gastroenterol; 2009 Jul; 104(7):1780-6. PubMed ID: 19436288
[TBL] [Abstract][Full Text] [Related]
20. [Secretin-stimulated MR cholangiopancreatography (MRCP): visualization of the normal pancreatic duct in comparison with ERCP].
Heverhagen JT; Battmann A; Kirsch M; Eissele R; Klose KJ; Wagner HJ
Rofo; 2002 Sep; 174(9):1154-7. PubMed ID: 12221575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
